ICTI News
Interactive Clinical Technologies Incorporated (ICTI) is pleased to announce that it recently successfully completed implementation of a Storage Area Network (SAN).
Yardley, PA -- May 5, 2005 - Interactive Clinical Technologies Incorporated (ICTI) is pleased to announce that it recently successfully completed implementation of a Storage Area Network (SAN). The SAN is but one component of ICTI's High Availability Strategy.
Putting ICTI at the forefront of the IVRS and EDC markets, the SAN provides full state-of-the-art backup and disaster recovery for ICTI's clients. By maintaining a complete copy of all of ICTI's data in a geographically separate, secure location, the SAN ensures the integrity of clients' data in the case of a disaster. Data are written to the SAN in real time so that, unlike commonly used data backup procedures, there is no loss of data at ICTI in the event that ICTI's main location is damaged and/or unavailable.
The SAN has massive capacity, not being limited in scalability or performance in the way that local area networks are. It also increases the efficiency of system resources, leaving more system resources available for clients' applications.
Our clients' clinical systems auditors in particular appreciate the data protection provided by the high reliability and high performance of ICTI's fully validated SAN implementation.
Fritz Haas, ICTI's Vice President of Information Systems, reflected, "While the implementation of the SAN was a technology project, the impetus behind it was our commitment to complete customer satisfaction. That commitment means that we need to provide 100% data security and reliability. The SAN, along with our robust network environment, provides clients with that security."
About ICTI and Almac Sciences
ICTI is a division of Almac Sciences that specializes in interactive solutions to accelerate the clinical trials process and reduce the costs of clinical trials. Our solutions include Interactive Voice Response (iVR) for patient randomization, dosing and clinical supply management; phone-based patient diaries; iTrial EDC for clinical trials data; and forecasting for clinical trials supplies planning.
Almac Sciences and its affiliated companies (CSS (Chemical Synthesis Services), CTS (Clinical Trial Services), ICTI (Interactive Clinical Technologies Incorporated), PDMS (Pharmaceutical Development and Manufacturing Services) and ArraDx (Array Based Diagnostics)) provide a broad range of services across drug discovery, diagnostics, pharmaceutical research and development, manufacture of API, clinical trials and drug product manufacture. US operations are based in Pennsylvania, North Carolina and California. European operations are headquartered in Craigavon, Northern Ireland with additional operations in London and Edinburgh.
Including Women of Childbearing Age in Clinical Research
March 26th 2024In recognition of International Women's Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and Marie Teil, Global Head of UCB’s Women of Childbearing Age Program. They speak about the specific challenges women with chronic illnesses face when accessing appropriate treatment and participating in clinical trials, UCB's Women of Childbearing Age Program and it’s most successful strategies, and much more.
Regulatory Compliance With eCOAs
April 26th 2024In the fourth and final part of this video interview with ACT editor Andy Studna, Melissa Mooney, director, eCOA sales engineering, IQVIA discusses how the regulatory stance on electronic clinical outcome assessments has changed over the years and what it could look like in the future.
Improving Engagement While Maintaining Data Integrity & Validity
March 19th 2024In recognition of Women's Health Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and uMotif's Chief Product Officer, Julia Lakeland, discuss new technologies improving patient engagement and reducing the emotional and logistical burdens of participation, ethical considerations that should be addressed when implementing those technologies, while ensuring patient privacy, and much more.
Using Patient Reported Outcomes in Dermatology Trials
April 25th 2024In part 3 of this video interview with ACT editor Andy Studna, Melissa Mooney, director, eCOA sales engineering, IQVIA sheds light on the unique challenges of dermatology trials and how clinical outcome assessments can be implemented in them.
